|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and cash equivalents | |||||||||
| Financial assets | |||||||||
| Accounts and other receivable, net | |||||||||
| Inventory, net | |||||||||
| Other assets | |||||||||
| Current Assets | |||||||||
| Non-Current Assets | |||||||||
| Financial assets | |||||||||
| Accounts and other receivable, net | |||||||||
| Other assets | |||||||||
| Property, plant and equipment | |||||||||
| Deferred income tax assets | |||||||||
| Intangible assets | |||||||||
| Equity accounted investments | |||||||||
| Goodwill | |||||||||
| Total assets | |||||||||
| Liabilities and Equity | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and other | |||||||||
| Liabilities associated with assets held for sale | |||||||||
| Non-recourse borrowings in subsidiaries of the partnership | |||||||||
| Current Liabilities | |||||||||
| Non-Current Liabilities | |||||||||
| Accounts payable and other | |||||||||
| Corporate borrowings | |||||||||
| Non-recourse borrowings in subsidiaries of the partnership | |||||||||
| Deferred income tax liabilities | |||||||||
| Total liabilities | |||||||||
| Equity | |||||||||
| Limited partners | |||||||||
| Non-controlling interests attributable to: | |||||||||
| Redemption-exchange units | |||||||||
| Special limited partner | |||||||||
| BBUC exchangeable shares | |||||||||
| Preferred securities | |||||||||
| Interest of others in operating subsidiaries | |||||||||
| Total equity | |||||||||
| Total liabilities and equity | |||||||||
Loading...
